Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
New materials help assess medicines policies and interventions
A new (and improved) model to regulate pharmaceutical promotion
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
Bayer CEO's callous comments highlight failure of current biomedical innovation model
Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed
Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed
Regulation critical to clinical trials data transparency in Europe
When politicians go to the movies
True clinical trials transparency? Not quite, EFPIA.
Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’
Good week for access to affordable medicines
Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency
Bracing for another delay – open innovation at the WHO?